Document:

EX-4.1

Exhibit 4.1

CERTIFICATE OF DESIGNATIONS

OF THE

SERIES B PARTICIPATING PREFERRED STOCK

OF

JUNIPER CONTENT CORPORATION

 

Pursuant to Section 151 of the

General Corporation Law of the State of Delaware

 

     Juniper Content Corporation, a Delaware corporation (hereinafter called the “Company”), hereby
certifies that, pursuant to the authority expressly vested in the Board of Directors of the Company
by the Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”), and
in accordance with the provisions of Sections 103 and 151 of the General Corporation Law of the
State of Delaware, the Board of Directors has duly adopted the following resolutions.

     RESOLVED, that, pursuant to Article Fourth of the Certificate of Incorporation (which
authorizes 5,000 shares of preferred stock, $0.0001 par value per share (“Preferred Stock”)), the
Board of Directors hereby fixes the powers, designations, preferences and relative, participating,
optional and other special rights, and the qualifications, limitations and restrictions, of a
series of Preferred Stock. Terms that are not otherwise defined shall have the meanings ascribed
to them in Section 7.

     RESOLVED, that each share of such series of Preferred Stock shall rank equally in all respects
and shall be subject to the following provisions:

     Section 1. Designation and Amount: Stated Capital. The shares of such series shall be
designated as “Series B Participating Preferred Stock” (the “Series B Preferred Stock”), the par
value thereof shall be $0.0001 per share and the number of shares constituting the Series B
Preferred Stock shall be 1,750.

     Section 2. Rank.

     The Series B Preferred Stock shall, with respect to rights on dividends, liquidation,
dissolution and winding up, rank senior to all classes of the Company’s common stock, $0.0001 par
value per share (the “Common Stock”), the Company’s Senior 7% Convertible Series A Preferred Stock,
$.0001 par value per share and each other class of share capital of the Company established
hereafter by the Board of Directors of the Company, the terms of which do not expressly provide
that it ranks on a parity with or senior to the Series B Preferred Stock as to rights on dividends,
liquidation, winding-up and dissolution of the Company (collectively referred to as “Junior
Securities”). The Company shall not issue any capital stock that has parity

 

 

with, or is ranked senior to, the Series B Preferred Stock without the written consent of the
holders of a majority of the Series B Preferred Stock.

     Section 3. Dividends and Distributions.

          (a) The holders of shares of Series B Preferred Stock shall be entitled to receive cumulative
dividends compounded annually at the rate of 8% of the Stated Value (as defined in Section 7 below)
of a share of the Series B Preferred Stock per annum.

          (b) Dividends shall be payable in cash or in shares of Series B Preferred Stock valued at the
Stated Value at the option of the holder of the Series B Preferred Stock. Each holder of shares of
Series B Preferred Stock shall provide the Company with written notice at least five days in
advance of each Dividend Payment Date (defined below) as to whether dividends will be payable in
cash or in shares of Series B Preferred Stock. Once such notice is given, the Company shall pay
each holder dividends in the same manner unless otherwise notified. If notice is not provided to
the Company as indicated above, payment of dividends shall be made in shares of Series B Preferred
Stock. In the event that there is an insufficient number of shares of Series B Preferred Stock to
pay all dividends in additional shares of Series B Preferred Stock, (i) the Company shall use its
best efforts to cause its stockholders to approve an amendment to the Company’s Certificate of
Incorporation to increase the number of authorized shares of preferred stock to provide for such
additional issuances of shares of Series B Preferred Stock and (ii) all dividends until such time
shall be paid only in cash.

          (c) Dividends shall be payable quarterly on each March 31, June 30, September 30 and December
31 (each, a “Dividend Payment Date”). Each such dividend will be payable on each of the Dividend
Payment Dates to the holders of record of shares of the Series B Preferred Stock, as they appear on
the stock records of the Company at the close of business 10 days prior to such Dividend Payment
Date. Each such dividend shall be payable prior to the payment of any dividends on, redemption of,
or repurchase of, any other capital stock of the Company.

     Section 4. Liquidation Preference.

          (a) In the event of any Liquidation Event, as defined in Section 4(c), before any payment or
distribution of the assets of the Company (whether capital or surplus) shall be made to or set
apart for the holders of Junior Securities, the holders of each share of Series B Preferred Stock
shall be entitled to receive an amount per share equal to the Liquidation Value (as defined in
Section 7, below) of such shares on the date of distribution.

          (b) If, upon any Liquidation Event, the assets of the Company, or proceeds thereof,
distributable shall be insufficient to pay in full the preferential amount aforesaid to the holders
of the shares of Series B Preferred Stock, then the assets of the Company, or the proceeds thereof,
shall be distributed among the holders of shares of Series B Preferred Stock ratably in accordance
with the respective amounts that would be payable on such shares of Series B Preferred Stock if all
amounts payable thereon were paid in full.

          (c) A Liquidation Event shall mean (i) any liquidation, dissolution or winding up of the
Company, whether voluntary or involuntary, (ii) any sale, conveyance, exchange or

2

 

transfer of all or substantially all of the property or assets of the Company or (iii) any
sale of equity interests, merger, reorganization or other transaction pursuant to which (y) the
majority of the Company’s Board of Directors immediately prior to such event are not the majority
of the Company’s Board of Directors immediately after such event or (z) any person or entity, or
group of affiliated persons or entities, becomes the beneficial owner (as such term is defined in
Rule 13d-3 of the Securities Exchange Act of 1934), other than the Company’s existing officers,
directors or their affiliates, of the majority of the outstanding voting stock of the Company
immediately after such event.

     Section 5. Mandatory Redemption.

          (a) At any time after January 15, 2013, the holders of the Series B Preferred Stock shall have
the right (“Redemption Right”), exercisable by Super-Majority Vote together with written notice to
the Company, to require the Company to redeem all, and not less than all, of the Series B Preferred
Stock for cash within 45 days of receipt of the notice of the exercise of the Redemption Right at a
redemption price per share equal to the Liquidation Value per share (the “Redemption Price”).

          (b) Redemption Payments. For each share of Series B Preferred Stock that is to be
redeemed hereunder, the Company shall be obligated on the Redemption Date to pay to the holder
thereof (upon surrender by such holder at the Company’s principal office of the certificate
representing such share of Series B Preferred Stock) an amount in cash in immediately available
funds as required pursuant to Section 5(a). If the funds of the Company legally available
for redemption of shares of Series B Preferred Stock on any Redemption Date are insufficient to
redeem all of the shares of Series B Preferred Stock to be redeemed on such date, those funds that
are legally available shall be used to redeem the maximum possible number of Shares of Series B
Preferred Stock pro rata among the holders of the shares of Series B Preferred Stock to be redeemed
based upon the amount due to each such holder pursuant to Section 5(a). At anytime
thereafter when additional funds of the Company are legally available for the redemption of shares
of Series B Preferred Stock, such funds shall immediately be used to redeem the balance of the
shares of Series B Preferred Stock that it has not redeemed.

          (c) Certificates; Rights. With regard to any redemption that has been requested in
accordance with this Section 5, for so long as any shares of Series B Preferred Stock remain
outstanding on or before the applicable date that redemption is required, each holder of shares of
Series B Preferred Stock shall surrender such holder’s certificates representing the shares to be
redeemed at the headquarters of the Company and thereupon the applicable Redemption Price of such
shares shall be payable to the order of the person whose name appears on such certificate or
certificates as the owner thereof and each surrendered certificate shall be canceled and retired.

          (d) Failure to Redeem. In the event the Company fails to redeem the Series B
Preferred Stock upon the exercise of the Redemption Right, the holders of a majority of the Series
B Preferred Stock shall have the option to elect a majority of the Board of Directors of the
Company for the purpose of effecting the redemption of the Series B Preferred Stock through a sale
of the Company; provided that any sale shall be performed in an orderly auction (unless

3

 

otherwise approved by Super-Majority Vote) in a manner consistent with the directors’
discharge of their fiduciary duties.

     Section 6. Voting Rights.

          (a) The holders of record of shares of Series B Preferred Stock (the “Series B Holders”) shall
be entitled to the following voting rights, as more fully described in paragraph 6(b) below:

               (i) with respect to those matters requiring a separate class vote under applicable law or
contract, the right to vote their shares of Series B Preferred Stock; and

               (ii) the right to vote together with the holders of the Common Stock on a Common Equivalent
Basis upon any matter submitted to the holders of the Common Stock for a vote.

               (iii) the Series B Holders shall have the right to elect two directors (the “Series B
Preferred Directors”) to the Company’s Board of Directors. The Series B Preferred Directors must
be approved by the Company prior to becoming directors, but the Company may not unreasonably
withhold its approval. The Series B Holders shall have the option in their sole discretion to
irrevocably terminate the right to elect any of the Series B Preferred Directors and instead have
the right (during the same period) to elect Board observers (“Observers”). The Series B Preferred
Directors or Observers, as the case may be, shall receive timely notice of all meetings in the same
manner as members of the board and shall be reimbursed for all reasonable expenses incurred in
connection with his attendance at each meeting. The Company may exclude the Observers and require
them to sign a non-disclosure agreement in customary form. The Company shall deliver to the Series
B Preferred Directors or Observers the minutes of each Board meeting and to the extent the
Observers may have been excluded from any such meeting, redacted to remove the information relating
to such period of time during which the Observers were excluded, as soon as such minutes are
distributed to the other members of the Board of Directors.

          (b) (i) Each issued and outstanding share of the Series B Preferred Stock shall be entitled to
one vote if entitled to vote as a separate class and the vote of the holders of at least a majority
of the then outstanding Series B Preferred Stock shall bind the entire class of Series B Preferred
Stock, except as otherwise provided in this Certificate. The Company shall give the holders of the
Series B Preferred Stock at least ten (10) days’ prior written notice of any matter to be submitted
to such holders for a vote as a separate class.

               (ii) If the holders of the Series B Preferred Stock are voting together with the holders of
the Common Stock, each holder of the Series B Preferred Stock shall be entitled to vote on a Common
Equivalent Basis. The Company shall give the holders of the Series B Preferred Stock the same
notice it gives to the holders of Common Stock on issues on which the Series B Preferred Stock and
Common Stock vote together and if the action is to be taken by written consent, at least one
business day prior to the date of such written consent.

     Section 7. Definitions. The following terms, as used herein, shall have the following
meanings:

4

 

          “Common Equivalent Basis” of the Series B Preferred Stock will be equal to the number of
shares of Series B Preferred Stock outstanding divided by the Conversion Rate.

          “Conversion Rate” as used herein means the product of (X) 0.001 multiplied by (Y) $0.10. In
case the Company shall at any time (A) declare a dividend or make a distribution on Common Stock
payable in Common Stock, (B) subdivide or split the outstanding Common Stock, (C) combine or
reclassify the outstanding Common Stock into a smaller number of shares or (D) consolidate with, or
merge with or into, any other Person, or engage in any reorganization, reclassification or
recapitalization that is effected in such a manner that the holders of Common Stock are entitled to
receive stock, securities, cash or other assets with respect to or in exchange for Common Stock
(other than as a cash dividend or distribution declared by the Company), the Conversion Rate shall
be adjusted accordingly.

          “Liquidation Value” on any date means, with respect to one share of Series B Preferred Stock,
two times the Stated Value, plus any dividends accrued and unpaid through the date of liquidation
(or conversion, as the case may be); provided, however, that if the Liquidation Event is the sale
by the Company of equity or all or substantially all of its assets (by way of sale, merger,
acquisition or other similar transaction) for an amount in excess of $8,000,000, then the
Liquidation Value shall be reduced to an amount equal to the Stated Value, plus any dividends
accrued and unpaid through the date of liquidation (or conversion, as the case may be).

          “Person” as used herein means any corporation, limited liability company, partnership, trust,
organization, association, other entity or individual.

          “Stated Value” equals, with respect to one share of Series B Preferred Stock, $1,000, as may
be adjusted under the terms hereof.

          “Super-Majority Vote” as used herein means the election in writing by the holders of at least
66-2/3% of the then outstanding shares of Series B Preferred Stock.

     Section 8. Reacquired Shares. Any shares of Series B Preferred Stock exchanged,
converted, redeemed, purchased or otherwise acquired by the Company in any manner whatsoever shall
be retired and cancelled promptly after the acquisition thereof and shall upon cancellation be
restored to the status of authorized but unissued shares of preferred stock, subject to reissuance
by the Board of Directors as shares of preferred stock of one or more other series but not as
shares of Series B Preferred Stock.

     Section 9. Adjustment for Stock Split or Subdivision. In the event that the Series B
Preferred Stock is combined or subdivided, through a stock split, reverse split, or otherwise, all
references to share numbers and per share amounts (including dividends) will be appropriately
adjusted to take such action into account.

5

 

     IN WITNESS WHEREOF, the Company has caused this certificate to be signed by Stuart B. Rekant,
its Chief Executive Officer, on this 11th day of February, 2009.

	 	 	 	 	 
	 	JUNIPER CONTENT CORPORATION

 	 
	 	By:  	/s/ Stuart B. Rekant
 	 
	 	 	Name:  	Stuart B. Rekant 	 
	 	 	Title:  	Chief Executive Officer 	 
	 

6EX-10.1

Exhibit 10.1

 

SECURITIES PURCHASE AGREEMENT

BETWEEN

JUNIPER CONTENT CORPORATION

AND

CERTAIN INVESTORS

 

Dated: February 11, 2009

 

 

SECURITIES PURCHASE AGREEMENT

     THIS SECURITIES PURCHASE AGREEMENT (the “Agreement”) is made as of the 11th day of
February 2009, by and between Juniper Content Corporation, a Delaware corporation (“Company”), and
each person or entity whose name appears on Schedule I (each an “Investor” and collectively, the
“Investors”).

W I T N E S S E T H:

     WHEREAS, the Company proposes to sell up to $1,500,000 of principal amount Senior Secured
Convertible Notes due August 31, 2009 (“Notes”) in a private placement (“Offering”) to “accredited
investors” with a minimum investment of a Note with a principal amount of $10,000 (“Private
Placement Minimum”);

     WHEREAS, the Notes will be secured by a lien and security interest covering all of the assets
of the Company, Firestone Communications, Inc. and Sorpresa! Rights LLC, each a wholly owned
subsidiary of the Company, pursuant to a security agreement between such parties and the Investors
(“Security Agreement”) and will be convertible into shares of the Company’s Series B Participating
Preferred Stock (“Series B Preferred”); and

     WHEREAS, the Company and the Investors are executing and delivering this Agreement in reliance
upon the exemption from securities registration afforded by Section 4(2) of the Securities Act of
1933, as amended (“Securities Act”), and Rule 506 of Regulation D (“Regulation D”) as promulgated
under the Securities Act.

     NOW THEREFORE, in consideration of the mutual covenants and agreements set forth in this
Agreement, and for other good and valuable consideration, the receipt and sufficiency of which are
hereby acknowledged, the parties do hereby agree as follows:

     1. Securities Purchase. Subject to the terms and conditions of this Agreement, each
Investor hereby purchases from the Company, and the Company hereby issues and sells to each
Investor (the “Securities Purchase”), the principal amount of Notes for an aggregate purchase price
(“Purchase Price”) as set forth opposite each Investor’s name on Schedule I. The form of Note is
attached as Exhibit A, the form of Security Agreement to secure the Company’s obligations under the
Notes is attached as Exhibit B and the form of Certificate of Designations, Preferences and Rights
for the Series B Preferred is attached as Exhibit C.

     2. Purchase Price Rebate. Concurrently with the consummation of the Securities
Purchase, the Company is paying to certain Investors the cash sum, and issuing to it warrants
(“Rebate Warrants”) to purchase the number of shares of the Company’s Common Stock as set forth
opposite each Investor’s name on Schedule I, representing a rebate on the Purchase Price
(“Rebate”). The form of Rebate Warrants is attached as Exhibit D.

     3. Closing.

          3.1 The Securities Purchase is being consummated concurrently with the execution of this
Agreement (“Closing”) at the offices of Graubard Miller, The Chrysler Building, 405 Lexington
Avenue, 19th Floor, New York, New York 10174 at 10:00 a.m., on or

1

 

before February 11, 2009. Additional subsequent Closings may occur beyond the closing date
upon the mutual agreement of the Investors and the Company. Accordingly, (a) the Notes are being
delivered to the Investors by the Company, (b) the Purchase Price is being paid and delivered via
wire transfer to the Company by the Investors and (c) the Rebate Warrants are being delivered to
the Investors by the Company and the cash portion of the Rebate is being paid and delivered via
wire transfer to the Investors by the Company, concurrently with the execution of this Agreement.
The applicable wiring instructions of each party are set forth on Exhibit D hereto.

          3.2 As a condition of to the Securities Purchase, Stuart Rekant, the Chairman and Chief
Executive Officer of the Company (or parties associated with him or introduced by him) shall
purchase a Note or Notes in an aggregate amount of at least $150,000.

     4. Representations, Warranties and Covenants of the Company. The Company hereby makes
the following representations, warranties and covenants to the Investor as of the date hereof that:

          4.1 Organization, Organizational Documents.

          (a) The Company is a corporation duly organized, validly existing, and in good standing under
the laws of the State of Delaware, and has all requisite corporate power and authority to carry on
its business as now conducted. The Company is duly qualified and is in good standing in each
jurisdiction in which the failure so to qualify would not reasonably be expected to have,
individually or in the aggregate, a material adverse effect on the business, assets, properties,
rights and results of operations of the Company taken as a whole (“Material Adverse Effect”).

          (b) Attached as Schedule 4.1(b) hereto are correct and complete copies of the Amended
and Restated Certificate of Incorporation and the By-laws of the Company, including all amendments
thereto, each as in effect on the date hereof (collectively, the “Organizational Documents”). No
amendments, revisions or waivers of any provisions of any Organizational Documents are in the
process of occurring or otherwise have been requested.

          4.2 Subsidiaries. Except as set forth on Schedule 4.2, the Company (i) does
not presently own, directly or indirectly, an interest in any corporation, association or other
business entity and (ii) is not a party to any joint venture, partnership, or similar arrangement.

          4.3 Authorization. All corporate action on the part of the Company, its officers,
directors, and shareholders necessary for the (a) authorization, execution, issuance and/or
delivery of (i) this Agreement, (ii) the Notes, (iii) the Series B Preferred issuable upon
conversion of the Notes and the related Certificate of Designations, Preferences and Rights for the
Series B Preferred, (iv) the Security Agreement and (iv) the Rebate Warrants and the Warrant Shares
(defined below) (the foregoing hereinafter collectively referred to as the “Transaction Documents”)
and (b) the performance of all obligations of the Company hereunder and thereunder has been taken.
The Transaction Documents constitute valid and legally binding obligations of the Company,
enforceable against the Company in accordance with their

2

 

respective terms, except (1) as limited by applicable bankruptcy, insolvency, reorganization,
moratorium, fraudulent conveyance, fraudulent transfer and other laws of general application
affecting enforcement of creditors’ rights generally, (2) as limited by laws relating to the
availability of specific performance, injunctive relief, or other equitable remedies, and (3) to
the extent the indemnification and contribution provisions contained in the Transaction Documents
may be limited by applicable federal or state laws.

          4.4 No Conflict. The execution and delivery by the Company of this Agreement and the
other Transaction Documents, the consummation of the transactions contemplated hereby and thereby,
and the compliance with the provisions hereof and thereof, will not (i) violate or conflict with
any of the Organizational Documents, (ii) violate, conflict with, result in a breach of, constitute
a default under, or give rise to any right of termination, cancellation, or acceleration (with or
without notice or lapse of time, or both) under any material agreement, lease, security, license,
permit, or instrument to which the Company is a party, or to which it or its material assets or
businesses are subject, (iii) result in the imposition of any Encumbrance (as hereinafter defined)
on any material asset of the Company or (iv) violate or conflict with any Laws (as hereinafter
defined) applicable to the Company or its properties or assets, except in each case for such
violations, conflicts and Encumbrances which would not reasonably be expected to have, either
individually or in the aggregate, a Material Adverse Effect. For purposes of this Agreement,
“Encumbrance” means any security interest, mortgage, lien, pledge, charge, easement, reservation,
equities, rights of way, options, rights of first refusal and any other encumbrances, whether or
not relating to the extension of credit or the borrowing of money. For purposes of this Agreement,
“Laws” means all laws, statutes, rules, regulations, ordinances, bylaws, writs, permits, orders and
other legislative, administrative or judicial restrictions.

          4.5 Capitalization. The numbers of all authorized, issued and outstanding shares of
capital stock of the Company are set forth on Schedule 4.5 hereto. No holder of the
Company’s securities is entitled to preemptive or similar rights with respect to the Company’s
securities. Except as disclosed in Schedule 4.5 and as contemplated by the Transaction
Documents, there are no (i) outstanding securities exercisable or convertible into securities of
the Company, (ii) other outstanding options, warrants, script rights, calls, commitments or similar
rights or obligations relating to the Company’s securities, (iii) any other agreements, contracts,
commitments or understandings giving any person any right to subscribe for or acquire any of the
Company’s securities, or (iv) any other agreements, contracts, commitments or understandings by
which the Company is or may become bound to issue any of its securities.

          4.6 Registration Rights. Except as set forth on Schedule 4.6 hereto, no
holder of any of the Company’s securities or any other person has any registration rights with
respect to such securities.

          4.7 No Right to Receive or Purchase. Neither the issuance of the Notes sold
hereunder, the issuance of any shares of Series B Preferred upon conversion of the Notes
(“Conversion Shares”) nor the issuance of any shares of Common Stock upon exercise of the Rebate
Warrants (“Warrant Shares” and together with the Conversion Shares, the “Underlying Securities”)
will give any holder of any of the Company’s securities outstanding prior to such

3

 

issuance (a) the right to receive or purchase any additional securities of the Company or (b)
the right to an anti-dilution adjustment to any outstanding securities of the Company or securities
into or for which such outstanding securities may be exercised or converted.

          4.8 Valid Issuance; Underlying Securities; Outstanding Securities.

          (a) The Notes and Rebate Warrants when issued, sold, and delivered in accordance with the
terms of this Agreement, will be duly and validly issued, and, based in part upon the
representations of the Investor in this Agreement, will be issued in compliance with all applicable
federal and state securities laws.

          (b) Upon issuance in accordance with the terms of the Notes and Rebate Warrants, all
Underlying Securities shall be duly and validly issued, fully paid and nonassessable, and issued in
compliance with all applicable Laws, as presently in effect

          (c) All outstanding securities of the Company were duly and validly authorized and issued, are
fully paid and nonassessable, and were issued in compliance with all applicable federal and state
securities laws.

          4.9 Filings, Consents and Approvals. The Company is not required to obtain any
consent, waiver, authorization or order of, give any notice to, or make any filing or registration
with, any court or other federal, state, local or other governmental authority or other person in
connection with the execution, delivery and performance by the Company of the Transaction
Documents, other than (a) a Form D in accordance with Regulation D, (b) a Current Report on Form
8-K disclosing the sale of unregistered securities and any other event of which disclosure is
required, (c) applicable Blue Sky filings, (d) such filings as may be necessary to perfect the
security interest granted to the Investors under the Security Agreement and (e) where the failure
to obtain such consent, waiver, authorization or order, or to give such notice or make such filing
or registration would not reasonably be expected to have, either individually or in the aggregate,
a Material Adverse Effect.

          4.10 Financial Information.

          (a) As of the Closing, the Company has the approximate amount of cash and receivables as
indicated on Schedule 4.10(a).

          (b) Schedule 4.10(b) sets forth the unaudited balance sheet of the Company at
September 30, 2008 (the “Balance Sheet”) and the related statements of operations, shareholders’
equity and cash flows of the Company for the nine months then ended (collectively, the “Financial
Statements”).

          (c) The Financial Statements present fairly in all material respects the financial position of
the Company and the results of operations, shareholders’ equity and cash flows of the Company at
the dates and for the periods indicated.

          (d) Except as incurred under the existing terms of any Disclosed Agreement (as defined below
in Section 4.15(a)), at the date of the Balance Sheet, the Company did not have

4

 

any material Liability (as hereinafter defined) of any nature or any loss contingency (as such
term is used in the Statement of Financial Accounting Standards No. 5 issued by the Financial
Accounting Standards Board in March 1975) that should have been disclosed or provided for on the
Balance Sheet and that was not adequately disclosed or provided for on the Balance Sheet, including
the notes thereto. For purposes of this Agreement, “Liability” means any liability or obligation,
whether known, asserted or unasserted, absolute or contingent, accrued or unaccrued, liquidated or
unliquidated and whether due or to become due, regardless of when asserted.

          4.11 Absence of Changes; Review of Interim Financials.

          (a) Since the date of the Balance Sheet and except as contemplated by the Transaction
Documents and as set forth on Schedule 4.11, there has not been:

          (i) any change in the assets, liabilities or financial condition of the Company, except
for changes (i) in the ordinary course of business or (ii) which in the aggregate have not
resulted in and would not reasonably be expected to result in a Material Adverse Effect;

          (ii) any event or change that would reasonably be expected to result in a Material
Adverse Effect, individually or in the aggregate, whether or not insured against;

          (iii) any damage, destruction or loss (whether or not covered by insurance) affecting
any asset of the Company in excess of $50,000;

          (iv) any material Liability or loss contingency incurred by the Company that would have
to be disclosed on financial statements (including the notes thereto) (on a consolidated
basis) in accordance with United States generally accepted accounting principles (“U.S.
GAAP”), other than liabilities incurred in the ordinary course of business consistent with
past practice;

          (v) any commitment to borrow money from or provide financial support to any person or
entity entered into by the Company;

          (vi) any payment or discharge of any material Liability by the Company outside the
ordinary course of business consistent with past practice;

          (vii) any sale, assignment, license, or other disposition of any material asset or
right of the Company outside the ordinary course of business consistent with past practice;

          (viii) any declaration or payment of any dividend or other distribution with respect to
any shares of capital stock of the Company, or the direct or indirect acquisition of any
equity securities by the Company;

5

 

          (ix) any labor trouble, problem or grievance affecting the business of the Company
other than such matters which would not reasonably be expected to have a Material Adverse
Effect;

          (x) any capital expenditure or commitment therefor by the Company or any subsidiary for
additions to property, plant or equipment in excess of $50,000;

          (xi) any change in the accounting or tax methods, practices, or assumptions therefor
followed by the Company; or

          (xii) any other transaction or event not in the ordinary course of business consistent
with past practice that the Investor has not been advised of.

          (b) The Company’s independent accountants have not advised the Company that the Financial
Statements (i) do not comply in all material respects with the applicable accounting requirements
of the Securities Act and the related published rules and regulations thereunder or (ii) are not in
conformity with U.S. GAAP (except for the lack of complete footnotes and subject to year-end audit
adjustments).

          4.12 Litigation. Except as disclosed on Schedule 4.12, there is no action,
suit, proceeding, claim or investigation pending or, to the knowledge of the Company, currently
threatened against the Company which questions the validity of the Transaction Documents, or the
right of the Company to enter into any of them, or to consummate the transactions contemplated
hereby or thereby, or which would reasonably be expected to have, either individually or in the
aggregate, a Material Adverse Effect or cause any change in the current equity ownership of the
Company, nor is the Company aware that there is any basis for the foregoing. The foregoing
includes, without limitation, actions, pending or threatened (or any basis therefor known to the
Company), involving the prior employment of any of the Company’s employees, their use in connection
with the Company’s business of any information or techniques allegedly proprietary to any of their
former employers, or their obligations under any agreements with prior employers. The Company is
not a party or subject to the provisions of any order, writ, injunction, judgment, or decree of any
court or government agency or instrumentality.

          4.13 Intellectual Property.

          (a) The Company has sufficient right, title and/or interest in, or has otherwise acquired use
rights with respect to all proprietary rights and processes and intellectual property owned by or
licensed to the Company (collectively, the “Intellectual Property”) necessary for its business as
now conducted and, to the best knowledge of the Company, without any conflict with or infringement
of the rights of others.

          (b) The Company has not received any communications alleging that the Company has violated or,
by conducting its business as currently conducted would violate any of the patents, trademarks,
service marks, trade names, copyrights, or trade secrets, or other proprietary rights of any other
person or entity. The Company is not aware that any of its

6

 

employees, officers, or consultants are obligated under any contract (including licenses,
covenants, or commitments of any nature) or other agreement, or subject to any judgment, decree, or
order of any court or administrative agency, that would interfere with the use of such employee’s,
officer’s, or consultant’s commercially reasonable efforts to promote the interests of the Company
or that would conflict with the Company’s business as currently conducted. None of the execution
or delivery of the Transaction Documents, or the carrying on of the Company’s business as currently
conducted by the employees of the Company, or the conduct of the Company’s business as currently
conducted, will, to the Company’s knowledge, conflict with or result in a breach of the terms,
conditions, or provisions of, or constitute a default under, any contract, covenant, or instrument
under which any of such employees, officers or consultants are now obligated.

          4.14 Compliance with Other Instruments. The Company is not in violation or default of
any provisions of its Amended and Restated Certificate of Incorporation or Bylaws or, of any
instrument, judgment, order, writ, decree, mortgage, indenture, lease, license or contract to which
it is a party or by which it is bound or, to its knowledge, of any provision of federal, state, or
local statute, rule, or regulation applicable to the Company, except as would not reasonably be
expected to have, either individually or in the aggregate, a Material Adverse Effect.

          4.15 Agreements.

          (a) All material written contracts, agreements, licenses, commitments, instruments and
understandings (“Disclosed Agreements”) are set forth in the Company’s public filings.

          (b) Each Disclosed Agreement is in full force and effect and constitutes a valid and binding
obligation of the Company and to the knowledge of the Company, the other parties thereto. Except
as set forth on Schedule 4.15(b), the Company has performed in all material respects the
obligations required to be performed by it, is not in material default and has not received notice
alleging it to be in default under any such Disclosed Agreement. Except as set forth on
Schedule 4.15(b), to the knowledge of the Company, there exists no event or condition
which, after notice or lapse of time, or both, would constitute a material default under any
Disclosed Agreement. Except as set forth on Schedule 4.15(b), to the knowledge of the
Company, there are no material defaults by any other party to any such Disclosed Agreement. The
Company has made available to the Purchaser correct and complete copies of all Disclosed
Agreements.

          4.16 Employment Matters.

          (a) The Company is in compliance with all federal, state and local laws and regulations
respecting the employment of its employees and employment practices, terms and conditions of
employment and wages and hours relating thereto, except where noncompliance, singly or in the
aggregate, would not have a Material Adverse Effect.

7

 

           (b) To the Company’s knowledge, there are no pending investigations involving the Company by
the Department of Labor or any other governmental agency responsible for the enforcement of
employment laws and regulations. To the Company’s knowledge, there is no unfair labor practice
charge or complaint against the Company pending before a Labor Relations Board or any strike,
picketing, boycott, dispute, slowdown or stoppage pending or, to the best of the Company’s
knowledge, threatened against or involving the Company. No questions concerning representation
exist respecting the employees of the Company and no collective bargaining agreement or
modification thereof is currently being negotiated by the Company. The Company is not liable for
any severance pay or other payments to any employee or former employee that remains unsatisfied
arising from the termination of employment, other than payments to be made under terms of any
contract with terminated employees or that would not reasonably be expected to have, either
individually or in the aggregate, a Material Adverse Effect.

          (c) Except as set forth on Schedule 4.16(c) hereto, the Company neither maintains,
sponsors nor contributes to, nor is it required to contribute to, any program or arrangement that
is an “employee pension benefit plan,” an “employee welfare benefit plan,” or a “multi-employer
plan” as such terms are defined in Sections 3(2), 3(1) and 3(37), respectively, of the Employee
Retirement Income Security Act of 1974, as amended (“ERISA”) (“ERISA Plans”). The Company does not
maintain or contribute to a defined benefit plan, as defined in Section 3(35) of ERISA.

          4.17 Governmental Proceedings. There are no outstanding orders, judgments or decrees
of any court, governmental agency or other tribunal, domestic or foreign, naming the Company and
enjoining the Company from taking, or requiring the Company to take, any action, or to which the
Company, its properties or business is bound or subject.

          4.18 Permits. The Company has all franchises, permits, licenses, and any similar
authority necessary for the conduct of its business as now being conducted by it, except for those
by which the lack thereof would not be reasonably expected to have, either individually or in the
aggregate, a Material Adverse Effect. No such franchise, license or authority is scheduled to
expire or terminate sooner than one year from the date of this Agreement, except for those of which
the Company has no knowledge of any fact or circumstance that would make timely renewal or
replacement unreasonably difficult or expensive. The Company believes it can obtain, without undue
burden or expense, any similar authority for the conduct of its business as planned to be
conducted. The Company is not in default in any material respect under any of such franchises,
permits, licenses, or other similar authority.

          4.19 Compliance with Laws. The Company is in compliance with all Laws applicable to
its business as currently conducted, the violation of, or noncompliance with, which would
reasonably be expected to have, either individually or in the aggregate, a Material Adverse Effect
and the Company knows of no facts or set of circumstances which would give rise to any violation
of or noncompliance with such Law.

8

 

           4.20 Title to Property and Assets.

          (a) Schedule 4.20(a) sets forth all real property and material assets owned by the
Company. With respect to such real property and material assets the Company owns, such property
and assets free and clear of all mortgages, liens, loans, pledges, security interests, claims,
equitable interests, charges, and encumbrances, except such encumbrances and liens which arise in
the ordinary course of business and do not materially impair the Company’s ownership or use of such
property or assets.

          (b) Schedule 4.20(b) sets forth all real property and material assets leased by the
Company. With respect to the property and assets it leases, the Company is in compliance with such
leases and, to its knowledge, holds a valid leasehold interest free of any liens, claims, or
encumbrances.

          4.21 Taxes. The Company (i) has filed all tax returns that are required to have been
filed by it with all appropriate governmental agencies (and all such returns are true and correct);
and (ii) has paid all taxes or other assessments owed by it as indicated on such tax returns (other
than taxes the validity of which are being contested in good faith by appropriate proceedings).
The assessment of any additional taxes for periods for which returns have been filed is not to the
Company’s knowledge expected to exceed the recorded liability therefor and, to the Company’s
knowledge, there are no material unresolved questions or claims concerning the Company’s tax
liability. To the Company’s knowledge, the Company’s tax returns have not been reviewed or audited
by any taxing authority. To the Company’s knowledge, there is no pending dispute with any taxing
authority relating to any of said returns which, if determined adversely to the Company, would
result in the assertion by any taxing authority of any valid deficiency in a material amount for
taxes. The Company has withheld or collected from each payment made to each of its employees the
amount of all taxes, including, but not limited to, income taxes, Federal Insurance Contribution
Act taxes and Federal Unemployment Tax Act taxes required to be withheld or collected therefrom,
and has paid the same to the proper tax receiving officers or authorized depositaries.

          4.22 Insurance. The Company has in full force and effect insurance policies in the
manner and amount customary in the industry for companies in similar businesses similarly situated.

          4.23 Ranking of the Series B Preferred. As of the date hereof, no capital stock of
the Company ranks senior to or pari passu with the Series B Preferred and the Company currently has
no obligation or agreements to issue any such capital stock.

          4.24 Memorandum. Neither the Confidential Offering Memorandum nor any Transaction
Documents, as of their respective dates, contained any untrue statement of a material fact or
omitted to state a material fact required to be stated therein or necessary in order to make the
statements therein, in light of the circumstances under which they were made and based on any
limitations or qualifications set forth therein relating to such statements, not misleading, except
that this representation and warranty does not apply to statements in or omissions from the
Confidential Offering Memorandum or Transaction Documents made in reliance upon and in

9

 

conformity with information furnished to the Company, in writing by or on behalf of the
Investor for use therein.

          4.25 Blue Sky. The Company has caused or will cause to be timely filed with each
applicable jurisdiction corresponding to the residence of each Investor (as same has been provided
by such Investors) all appropriate documentation required for the registration of the Preferred
Shares and Warrants under applicable state law or required to secure an exemption from such
registration requirements.

          4.26 Current in SEC Filings. The Company has filed, in a timely fashion with the
Securities and Exchange Commission (the “SEC”), and is current with respect to such filings, all
reports, information statements, forms, correspondences and schedules required to be filed by it
pursuant to (i) Section 13 or Section 15(d) of the Securities Exchange Act of 1934, amended
(“Exchange Act”), (ii) the applicable rules and regulations thereunder, and (iii) any comments
requiring or requesting a response, directed to the Company by the SEC, and since July 13, 2005,
has maintained full compliance with the current public information requirements of Rule 144 and
Rule 144A promulgated under the Securities Act of 1933, as amended or any similar successor to
such rule.

          4.27 Indebtedness. Schedule 4.27 hereto sets forth as of the date hereof all
outstanding secured and unsecured Indebtedness of the Company or any Subsidiary, or Indebtedness
for which the Company or any Subsidiary has commitments. For the purposes of this Agreement,
“Indebtedness” shall mean any liabilities for borrowed money in excess of $15,000. Neither
the Company nor any Subsidiary is in default with respect to any Indebtedness.

     5. Representations and Warranties of the Investor. Each of the Investors hereby
severally represent and warrant to the Company as of the date hereof that:

          5.1 Authorization. The Transaction Documents to which such Investor is a signatory
constitute valid and legally binding obligations of such Investor, enforceable in accordance with
their respective terms, except (a) as limited by applicable bankruptcy, insolvency, reorganization,
moratorium, and other laws of general application affecting enforcement of creditors’ rights
generally, (b) as limited by laws relating to the availability of specific performance, injunctive
relief, or other equitable remedies, and (c) to the extent the indemnification provisions contained
in the Transaction Documents may be limited by applicable federal or state laws.

          5.2 Purchase Entirely for Own Account. The Notes, Rebate Warrants and Underlying
Securities will be acquired for investment for each Investor’s own account and not with a view to
the resale or distribution of any part thereof. Each Investor represents that it has full power
and authority to enter into this Agreement.

          5.3 No Public Market. Each Investor understands that no public market now exists for
the Notes, Conversion Shares and Rebate Warrants, and that the Company has made no assurances that
a public market will ever exist for such securities. Each Investor has substantial

10

 

experience in evaluating and investing in private placement transactions of securities in companies in similar stages as the Company so that
it is capable of evaluating the merits and risks of its investment in the Company and has the
capacity to protect its own interests and bear the risk of the investment in the Company.

          5.4 Disclosure of Information. Each Investor acknowledges that it has reviewed the
Confidential Offering Memorandum and all exhibits thereto and has been given an opportunity to
request additional information. Each Investor acknowledges that it has received all the
information that it has requested relating to the Company and the purchase of the Preferred Shares
and Warrants. Each Investor further represents that it has had an opportunity to ask questions and
receive answers from the management of the Company regarding the Company’s operations, assets and
financial results and terms and conditions of the Securities Purchase. The foregoing, however,
does not limit or modify the representations and warranties of the Company in Section 5 of this
Agreement or the right of such Investor to rely thereon.

          5.5 Accredited Investor. Each Investor is an “accredited investor” within the meaning
of Rule 501 of Regulation D of the SEC, as presently in effect, and, in the case of an Investor
that is an entity, such entity is comprised entirely of equity owners that are accredited
investors.

          5.6 Restricted Securities. Each Investor understands that the Notes, Rebate Warrants
and Underlying Securities are characterized as “restricted securities” under the federal securities
laws inasmuch as they are being acquired from the Company in a transaction not involving a public
offering, and that under such laws and applicable regulations such securities may be resold without
registration under the Act, only in certain limited circumstances. In this connection, each
Investor represents that it is familiar with SEC Rule 144, as presently in effect, and understands
the resale limitations imposed thereby and by the Act.

          5.7 Legends. It is understood that the certificates evidencing the Notes and Rebate
Warrants (and Underlying Securities) may bear the following (or substantially similar) legend:

“THE SECURITIES REPRESENTED BY THIS CERTIFICATE, AND THE SECURITIES UNDERLYING THIS
CERTIFICATE, HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE “ACT”), AND ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AS SET FORTH IN THIS
CERTIFICATE. THE SECURITIES REPRESENTED HEREBY MAY NOT BE SOLD, TRANSFERRED, OR
OTHERWISE DISPOSED OF IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER
THE ACT OR AN OPINION OF COUNSEL, REASONABLY ACCEPTABLE TO COUNSEL FOR THE COMPANY,
TO THE EFFECT THAT THE PROPOSED SALE, TRANSFER, OR DISPOSITION MAY BE EFFECTUATED
WITHOUT REGISTRATION UNDER THE ACT.”

11

 

     6. Certain Covenants and Obligations.

          6.1 Use of Proceeds. The Company will use the proceeds from the sale of the Notes for
working capital and general corporate purposes and for reasonable expenses to be incurred in
connection with the Offering.

          6.2 Reservation of Securities. The Company shall take all action necessary to at all
times have authorized, and reserved for the purpose of issuance, after the Closing, the Conversion
Shares and Warrant Shares.

          6.3 Board Rights. Upon issuance of the Series B Preferred upon conversion of the
Notes, the holders of the Series B Preferred shall have the right to appoint two directors
(“Preferred Directors”) to the Company’s Board of Directors. The Preferred Directors must be
approved by the Company prior to becoming directors, but the Company may not unreasonably withhold
its approval. The Company shall deliver to Juniper Venture LLC, as representative of the
Investors, written notice of such rejection within fifteen (15) calendar days of receipt of notice
of his or her designation.  The Company’s failure to deliver such notice shall constitute the
Company’s waiver of the right set forth above to reject such Preferred Directors, provided however
that such would not constitute a waiver of any rights and remedies the Company may otherwise have
to remove a Preferred Director pursuant to the Company’s By-Laws or Amended and Restated
Certificate of Incorporation or applicable law. At least one of the Preferred Directors shall be
appointed a member of the Company’s Compensation Committee, if one exists. The holders of the
Series B Preferred shall have the option in their sole discretion to irrevocably terminate the
right to appoint any of the Preferred Directors and instead have the right (during the same period)
to appoint Board observers (“Observers”). The Preferred Directors or Observers, as the case may be,
shall receive timely notice of all meetings (regardless of whether he shall be excluded from such
meeting as set forth below) including an agenda therefor to the extent one is provided to the
Board, in the same manner as members of the board and shall be reimbursed for all reasonable
expenses incurred in connection with his attendance at each meeting. The Company may exclude the
Observers from any scheduled meeting, or portion thereof, and require them to sign a non-disclosure
agreement in customary form. The Company shall deliver to the Preferred Directors or Observers the
minutes of each Board meeting and to the extent the Observers may have been excluded from any such
meeting, redacted to remove the information relating to such period of time during which the
Observers was excluded, as soon as such minutes are distributed to the other members of the Board
of Directors. The Company will indemnify the Preferred Directors or Observers, as the case may be,
in the same manner as its other directors, including the execution of a customary indemnification
agreement. The Company shall maintain directors’ and officers’ insurance in such amounts as may be
acceptable to the Company’s Board of Directors in their reasonable discretion, which insurance
shall cover the Preferred Directors. Section 6.4 below shall in no way restrict, amend or modify
the obligations of the Company set forth in this Section.

          6.4 Voting Agreement. Stuart B. Rekant, the Company’s Chief Executive Officer (the
“Stockholder”) and each of the Investors hereby agree that, commencing on the appointment of the
Preferred Directors and terminating on the five year anniversary of such appointment, (i) the
Stockholder will vote the shares of the Company’s common stock now

12

 

beneficially owned, or that may hereafter be acquired prior to the five year anniversary of
such appointment, for the election and re-election of the Preferred Directors and (ii) the
Investors will vote the shares of the Company’s common stock now beneficially owned, or that may
hereafter be acquired prior to the five year anniversary of such appointment, for the election and
re-election of the Stockholder or his designee as a director.

          6.5 Press Releases. The parties to this Agreement may not publicly disseminate a
press release or otherwise publicly announce the transactions contemplated by this Agreement,
except upon mutual consent or as may be required by law.

          6.6 Legal Fees and Other Expenses. All reasonable and documented legal and other fees
and expenses of the Investors in connection with this Agreement and the other Transaction Documents
(in no event to exceed $50,000) shall be paid concurrently with the closing of the Securities
Purchase.

          6.7 Securities Filings. The Company shall file in a timely fashion with the SEC, and
shall be current with respect to such filings, all reports, information statements, forms,
correspondences and schedules required to be filed by it pursuant to (i) Section 13 or Section
15(d) of the Securities Exchange Act of 1934, amended, (ii) the applicable rules and regulations
thereunder, and (iii) any comments requiring or requesting a response, directed to the Company by
the SEC, and shall maintain full compliance with the current public information requirements of
Rule 144 and Rule 144A promulgated under the Securities Act of 1933, as amended or any similar
successor to such rule.

          6.8 Securities Exchange Listing. The Company shall use commercially reasonable efforts
to apply for its Common Stock to be listed on a national stock exchange, including without
limitation on NASDAQ or the American Stock Exchange, within 60 days of becoming eligible to do so.

          6.9 Information Rights. The Company will provide to the Investors, within ten (10)
business days of the last business day of each calendar month, in addition to information issued to
shareholders and the public in its public filings, monthly financial reports that shall include,
but not be limited to, cash use summaries, revenues, accounts receivable detail and aging and
accounts payable detail and aging.

          6.10 Cash Outflows and Payables. The Company will (i) limit monthly cash outflows in
accordance with Exhibit F-1, (ii) manage payables in accordance with Exhibit F-2, (iii) limit
corporate overhead in accordance with Exhibit F-3 and (iv) limit monthly net cash outflows to
$150,000 per month if (a) revenue generated from Sorpresa Affiliate Fees and Sorpresa Advertising
Fees (net) (“Affiliate and Ad Revenue”) does not total at least $450,000 from January 1, 2009
through March 31, 2009 or (b) month ending cash balances fall below those set forth on Exhibit F-4
until such time as Affiliate and Ad Revenue for the preceding three months exceeds $500,000 and
monthly cash balances meet or exceed those set forth in Exhibit F-4.

13

 

          6.11 Further Assurances. The Company will take such actions as may be reasonably
required or desirable to carry out the provisions of this Agreement and the other Transaction
Documents.

     7. Company Deliveries at Closing. The Company shall deliver or cause the delivery of
each of the following to the Investors at the Closing:

          7.1 Securities Purchase Agreement. Its signature to this Agreement.

          7.2 Security Agreement. Signatures to the Security Agreement for it, Firestone
Communications, Inc. and Sorpresa! Rights LLC in the form attached hereto as Exhibit B.

          7.3 Opinion of General Counsel. An opinion, dated as of the date of the Closing, from
Graubard Miller, the Company’s general counsel, in the form attached hereto as Exhibit G.

          7.4 Good Standing Certificate. A certificate, dated as of a date within a reasonably
current date prior to the Closing, issued by the proper authority in Delaware to the effect that it
legally exists and in good standing.

          7.5 Secretary’s Certificate. A certificate, dated as of the date of the Closing,
executed by the Secretary of the Company certifying the resolutions adopted by the Company’s board
of directors relating to the transactions contemplated by the Transaction Documents.

          7.6 Delivery of Notes and Rebate Warrants. The Notes and Rebate Warrants as
specified, duly executed by the Company.

          7.7 Rebate. The cash portion of the Rebate via wire transfer.

          7.8 Cash Outflows and Payables. Cash outflow and payable budgets in the form attached
hereto as Exhibit F-1 through Exhibit F-4.

          7.9 Financing Statements. Financing statements in form and substance satisfactory to
the Investors.

     8. Deliveries by the Investor at the Closing. The Investors shall deliver or cause
the delivery of each of the following to the Company at the Closing:

          8.1 Securities Purchase Agreement. Their signatures to this Agreement.

          8.2 Security Agreement. Their signatures to the Security Agreement in the form
attached hereto as Exhibit B.

          8.3 Purchase Price. The Purchase Price by wire transfer.

     9. Indemnification. The Company agrees to indemnify and hold harmless the Investors
and any of Investors’ general partners, employees, officers, directors, members, agents

14

 

and other representatives (collectively, the “General Indemnitees”), against any
investigations, proceedings, claims or actions and for any expenses, damages, liabilities or losses
(joint or several) arising out of such investigations, proceedings, claims or actions, to which the
General Indemnitees may become subject, whether under the act or any rules or regulations
promulgated thereunder, the Exchange Act or any rules or regulations promulgated thereunder, or any
state law or regulation, or common law, arising out of any material breach of any representation,
warranty, agreement, obligation or covenant of the Company contained herein. The Company also
agrees to reimburse the General Indemnitees for any reasonable legal or other reasonable expenses
reasonably incurred in connection with investigating or defending any such investigations,
proceedings, claims or actions.

     10. Miscellaneous.

          10.1 Survival of Representation and Warranties. All of the representations and
warranties made herein shall survive the execution and delivery of this Agreement for a period of
one year, other than those made under Sections 4.1, 4.2, 4.3 and 4.26, which shall survive
indefinitely, and under Section 4.21, which shall survive for six months after the expiration of
the applicable statute of limitations. All of the covenants and other obligations set forth in
Section 6 shall survive the Closing in accordance with their terms. The Investors are entitled to
rely, and the parties hereby acknowledge that the Investors have so relied, upon the truth,
accuracy and completeness of each of the representations and warranties of the Company contained
herein, irrespective of any independent investigation made by the Investors. The Company is
entitled to rely, and the parties hereby acknowledge that the Company has so relied, upon the
truth, accuracy and completeness of each of the representations and warranties of the Investors
contained herein, irrespective of any independent investigation made by the Company.

          10.2 Successors and Assigns. This Agreement is personal to each of the parties and
may not be assigned without the written consent of the other parties.

          10.3 Governing Law. This Agreement shall be governed by and construed under the
internal law of the State of New York as applied to agreements among New York residents entered
into and to be performed entirely within New York. The Company (1) agrees that any legal suit,
action or proceeding arising out of or relating to this Agreement shall be instituted exclusively
in New York State Supreme Court, County of New York, or in the United States District Court for the
Southern District of New York, (2) waives any objection which the Company may have now or hereafter
to the venue of any such suit, action or proceeding, and (3) irrevocably consents to the
jurisdiction of the New York State Supreme Court, County of New York, and the United States
District Court for the Southern District of New York in any such suit, action or proceeding. The
Company further agrees to accept and acknowledge service of any and all process which may be served
in any such suit, action or proceeding in the New York State Supreme Court, County of New York, or
in the United States District Court for the Southern District of New York and agrees that service
of process upon the Company mailed by certified mail to the Company’s address shall be deemed in
every respect effective service of process upon the Company, in any such suit, action or
proceeding. THE PARTIES HERETO AGREE TO WAIVE THEIR RESPECTIVE RIGHTS TO A JURY TRIAL OF ANY CLAIM

15

 

OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF THIS AGREEMENT OR ANY DOCUMENT OR AGREEMENT
CONTEMPLATED HEREBY.

          10.4 Counterparts. This Agreement may be executed in counterparts, each of which
shall be deemed an original, but all of which together shall constitute one and the same
instrument. This Agreement, once executed by a party, may be delivered to the other party hereto
by facsimile transmission of a copy of this Agreement bearing the signature of the party so
delivering this Agreement.

          10.5 Titles and Subtitles. The titles and subtitles used in this Agreement are used
for convenience only and are not to be considered in construing or interpreting this Agreement.

          10.6 Notices. Unless otherwise provided, any notice, authorization, request or demand
required or permitted to be given under this Agreement shall be given in writing and shall be
deemed effectively given upon personal delivery to the party to be notified or three (3) days
following deposit with the United States Post Office, by registered or certified mail, postage
prepaid, or two days after it is sent by an overnight delivery service, or when sent by facsimile
with machine confirmation of delivery addressed as follows:

          If to an Investor, at the address, facsimile number or email address as set forth on
Schedule I

          If to Company:

Juniper Content Corporation

521 Fifth Avenue, Suite 822

New York, New York 10175

Fax: (212) 660-5931

Attention: Stuart B. Rekant

          In either case, with copies to:

Lev & Berlin, P.C.

200 Connecticut Avenue

Norwalk, CT 06854

Fax: (203) 854-1652

Attention: Duane L. Berlin, Esq. (e-mail : dberlin@levberlin.com)

          and

Graubard Miller

405 Lexington Avenue, 19th Floor

New York, New York 10174

Fax: (212) 818-8881

Attention: David Alan Miller, Esq. (e-mail: dmiller@graubard.com)

16

 

     Any party may change its address for such communications by giving notice thereof to the other
parties in conformity with this Section.

     11. No Broker Fees. Each party represents that it is not nor will it be obligated for
any finders’ or brokers’ fee or commission in connection with this transaction.

     12. Transaction Expenses; Enforcement of Transaction Documents. Except as provided
under Section 6.6, the Company and the Investors shall pay their respective costs and expenses
incurred with respect to the negotiation, execution, delivery and performance of this Agreement and
the other Transaction Documents. If any action at law or in equity is necessary to enforce or
interpret the terms of any Transaction Document, the prevailing party shall be entitled to
reasonable attorney’s fees, costs, and necessary disbursements in addition to any other relief to
which such party may be entitled.

     13. Amendments and Waivers. Any term of this Agreement may be amended and the
observance of any term of this Agreement may be waived (either generally or in a particular
instance and either retroactively or prospectively), only with the written consent of the Company
and a majority in interest of the holders of the Preferred Shares. Any amendment or waiver
affected in accordance with this paragraph shall be binding upon each holder of any securities
purchased under this Agreement at the time outstanding (including securities into which such
securities are convertible), each future holder of all such securities, and the Company.

     14. Severability. If one or more provisions of this Agreement are held to be
unenforceable under applicable law, such provision shall be excluded from this Agreement and the
balance of this Agreement shall be interpreted as if such provision were so excluded and shall be
enforceable in accordance with its terms.

     15. Entire Agreement. This Agreement and the documents referred to herein constitute
the entire agreement among the parties and no party shall be liable or bound to any other party in
any manner by any warranties, representations, or covenants except as specifically set forth herein
or therein.

17

 

     IN WITNESS WHEREOF, the parties have executed this Securities Purchase Agreement as of the
date first above written.

	 	 	 	 	 	 	 
	 	 	JUNIPER CONTENT CORPORATION	 	 
	 
	 	 	 	 	 	 
	 

	 	By:	 	 	 	 
	 

	 	Name:
	 	 

	 	 
	 

	 	Title:	 	 	 	 
	 
	 	 	 	 	 	 
	 
	 	 	 	 	 
	 	 	Stuart B. Rekant	 	 
	 	 	Solely with respect to Section 6.4	 	 

18

 

SCHEDULE I

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	Principal	 	 	 	 	 	 	 	Social Security	 	 
	Name and	 	Amount of	 	 	 	 	 	 	 	Number or Tax	 	 
	Address of	 	Notes	 	Purchase	 	 	 	Rebate	 	Identification	 	 
	Investor	 	Purchased	 	Price	 	Cash Rebate	 	Warrants	 	Number	 	Signature

19

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00152-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00152-of-00352.parquet"}]]